Table of Contents Table of Contents
Previous Page  146 / 258 Next Page
Information
Show Menu
Previous Page 146 / 258 Next Page
Page Background

1668

Butler-Thompson et al.

: J

ournal of

AOAC I

nternational

V

ol.

98, N

o.

6, 2015

Method

A few minor modifications were made to AOAC Official

First Action

2011.18

before it was sent to the multilaboratory

collaborative study participants. These changes included

updating the pulsed amperometric detector (PAD) program

and increasing the sodium hydroxide concentration from

750 mM to 1 M. The PAD program listed in AOAC

2011.18

,

First Action, was the waveform that was used when the method

was originally developed over 15 years ago using equipment

that is now obsolete. After First Action status was granted to

AOAC

2011.18

and before completion of the SPIFAN SLV

and multilaboratory collaborative study, the obsolete PAD

was replaced with a newer model, and the waveform listed in

AOAC

2011.18

was updated based on the recommendations

of the instrument manufacturer. The updated waveform was

added to the multilaboratory collaborative study protocol and to

AOAC

2011.18

, Final Action, and the previous waveform was

removed. It should be noted that whenever changes are made

to the PAD, the accuracy of the detector waveform should be

verified by analyzing an SRM and performing free myo-inositol

spike recovery experiments with an infant or adult formula

containing hydrolyzed protein.

It should also be noted that although the multilaboratory study

protocol specified using a standard (not disposable) gold electrode,

some participating laboratories used disposable gold working

electrodes. The instruction to not use disposable electrodes was

removed from the AOAC

2011.18

Final Action method.

After completion of the multilaboratory collaborative study,

the modifications noted above were incorporated in the Final

Action method along with a few additional modifications based

on study results and feedback from study participants and the

ERP.

For this reason, the method described below is slightly

different than the Official Final Action method currently posted

on the AOAC website.

AOAC Official Method 2011.18

Myo-Inositol (Free and Bound as

Phosphatidylinositol)

in Infant and Pediatric Formula

and Adult Nutritionals

Liquid Chromatography/Pulsed Amperometry

with Column Switching

First Action 2011

Final Action 2014

ISO–AOAC METHOD

The LC method with electrochemical (pulsed amperometry)

detection (PAD) allows for the quantitation of myo-inositol

in infant, pediatric, and adult nutritional formulas. The

concentration of myo-inositol is calculated by comparison

with standards of known concentration. Myo-inositol, as

defined by AOAC Standard Method Performance Requirement

(SMPR

®

) 2011.007 (free and bound as phosphatidylinositol), can

be calculated by adding the free myo-inositol and myo-inositol

bound as phosphatidylinositol data. The method was validated

for the quantitation of free myo-inositol and myo-inositol from

phosphatidylinositol in infant, pediatric, and adult nutritionals.

Repeatability was determined from duplicate analyses

performed on multiple days. Accuracy was determined from

spike recovery experiments (free myo-inositol and myo-inositol

from phosphatidylinositol). Instrument LODs and LOQs were

determined statistically from injections of low-level standards

and by spiking samples with low levels of free myo-inositol.

See

Tables

2011.18 A

C

for results of single- and multilaboratory

studies supporting acceptance of the method.

Caution

: Refer to Material Safety Data Sheets (MSDS) of

chemicals prior to use and follow safe handling

procedures and the suggested personal protective

equipment. Chloroform is a hazardous chemical

and should be handled in a fume hood. Perform the

phosphatidylinositol bound myo-inositol extraction

and SPE sample cleanup procedure in a fume hood.

A. Apparatus

(a) 

Analytical balance.

—Minimum weighing capacity of at

least 0.0001 g.

(b) 

Centrifuge.

(c) 

Desiccator.

(d) 

N-evap.

—With water bath (Organomation Associates,

Inc., Berlin, MA) or equivalent.

(e) 

Oven.

—Capable of maintaining 120°C.

(f ) 

pH meter.

—With pH 4 and 7 buffers.

(g) 

Stir plate.

—Multiposition with stir bars.

(h) 

Vacuum manifold.

(i) 

Vortex mixer.

(j) 

HPLC system.

—Corrosion-resistant components, including

an autosampler, two isocratic pumps, 6-port switching valve,

pulsed amperometry detector with a gold electrode and polyether

ether ketone or Teflon 0.007–.01 in. id tubing.Autosampler capable

of injecting 20 µL

.

(k) 

Columns.

—Dionex CarboPac MA1 (4 × 250 mm)

P/N 44066, MA1 (4 × 50 mm) P/N 44067, and PA1 (4 × 50 mm)

P/N 43096, or equivalen

t (www.thermofisher.com/dionex/).

B. Materials

(a) 

Beakers.

—Assorted sizes.

(b) 

Centrifuge tubes.

—50 mL with Teflon-coated caps.

(c) 

Syringe filters.

—Nylon, 0.45 and 0.2 μm.

(d) 

Filter paper.

—Whatman 2 V or equivalent (www.

whatman.com)

.

(e) 

Erlenmeyer flasks.

—50 or 125 mL or equivalent.

(f ) 

Volumetric flasks.

—Assorted sizes.

(g) 

Funnels.

—Suitable for use with filter paper.

(h) 

Pipets.

—Volumetric (Class A); assorted sizes.

(i) 

SPE cartridges.

—Silica, 1 g (J.T. Baker Inc., Phillipsburg,

NJ; P/N 7086-07,

www.avantormaterials.com)

or equivalent.

(j) 

Syringes.

—1 mL disposable and 25 mL gas-tight glass

with 4 in. stainless steel needles.

146